Erika Pintér Selected Research

Peroxidase (Myeloperoxidase)

5/2022	Investigation of the Role of the TRPA1 Ion Channel in Conveying the Effect of Dimethyl Trisulfide on Vascular and Histological Changes in Serum-Transfer Arthritis.
6/2020	Complex Regulatory Role of the TRPA1 Receptor in Acute and Chronic Airway Inflammation Mouse Models.
1/2019	TRPA1 Ion Channel Determines Beneficial and Detrimental Effects of GYY4137 in Murine Serum-Transfer Arthritis.
1/2018	Analgesic effects of the novel semicarbazide-sensitive amine oxidase inhibitor SZV 1287 in mouse pain models with neuropathic mechanisms: Involvement of transient receptor potential vanilloid 1 and ankyrin 1 receptors.
1/2017	Analgesic and Anti-Inflammatory Effects of the Novel Semicarbazide-Sensitive Amine-Oxidase Inhibitor SzV-1287 in Chronic Arthritis Models of the Mouse.
1/2016	Transient receptor potential ankyrin 1 (TRPA1) receptor is involved in chronic arthritis: in vivo study using TRPA1-deficient mice.
2/2015	Hemokinin-1 is an important mediator of endotoxin-induced acute airway inflammation in the mouse.
2/2015	Thermal spring water drinking attenuates dextran-sulfate-sodium-induced colitis in mice.
10/2014	Differential regulatory role of pituitary adenylate cyclase-activating polypeptide in the serum-transfer arthritis model.
8/2009	Impaired defense mechanism against inflammation, hyperalgesia, and airway hyperreactivity in somatostatin 4 receptor gene-deleted mice.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erika Pintér Research Topics

Disease

27	Inflammation (Inflammations) 01/2023 - 05/2004
25	Hyperalgesia 05/2022 - 08/2002
18	Pain (Aches) 01/2023 - 09/2004
14	Arthritis (Polyarthritis) 01/2023 - 05/2004
9	Edema (Dropsy) 01/2019 - 05/2007
8	Neurogenic Inflammation 09/2016 - 08/2002
7	Neuralgia (Stump Neuralgia) 12/2023 - 09/2003
7	Dermatitis 04/2022 - 12/2005
6	Hyperplasia 07/2018 - 05/2007
5	Hypersensitivity (Allergy) 02/2021 - 08/2009
5	Pneumonia (Pneumonitis) 06/2020 - 01/2008
5	Bronchial Hyperreactivity 06/2020 - 05/2007
4	Demyelinating Diseases (Demyelinating Disease) 01/2020 - 12/2016
3	Rheumatoid Arthritis 01/2019 - 10/2014
3	Allergic Contact Dermatitis 01/2016 - 12/2005
3	Colitis 02/2015 - 01/2014
2	Gingival Hyperplasia 10/2022 - 07/2018
2	Chronic Pain 09/2022 - 06/2006
2	Body Weight (Weight, Body) 05/2022 - 04/2022
2	Hypotension (Low Blood Pressure) 01/2022 - 07/2005
2	Hyperglycemia 02/2021 - 03/2016
2	Diabetes Complications 02/2021 - 03/2016
2	Hypertension (High Blood Pressure) 01/2021 - 07/2018
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 01/2018
2	Experimental Arthritis 01/2016 - 07/2005
2	Contact Dermatitis (Eczema, Contact) 01/2016 - 12/2005
2	Burns 06/2013 - 10/2005
1	Pancreatitis 10/2023
1	Intervertebral Disc Displacement (Herniated Disc) 07/2023
1	Scoliosis 07/2023
1	Stomach Ulcer (Gastric Ulcer) 01/2023
1	Surgical Wound 10/2022
1	Dental Plaque 10/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022
1	Neuroinflammatory Diseases 01/2022

Drug/Important Bio-Agent (IBA)

16	Capsaicin (Zostrix)FDA Link 01/2023 - 05/2004
15	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 07/2023 - 08/2002
11	Peroxidase (Myeloperoxidase)IBA 05/2022 - 05/2007
11	NeuropeptidesIBA 09/2016 - 08/2002
9	Analgesics (Analgesic Drugs)IBA 01/2023 - 05/2004
8	AnkyrinsIBA 01/2022 - 01/2016
7	CarrageenanIBA 10/2022 - 10/2005
6	somatostatin receptor subtype-4IBA 01/2023 - 06/2006
6	resiniferatoxinIBA 12/2019 - 09/2003
6	TRPV1 receptorIBA 09/2015 - 07/2005
5	TT2-32IBA 01/2023 - 08/2002
5	Peptides (Polypeptides)IBA 01/2022 - 10/2010
5	LipopolysaccharidesIBA 06/2020 - 05/2007
5	TachykininsIBA 01/2017 - 10/2010
5	EndotoxinsIBA 02/2015 - 05/2007
4	Proteins (Proteins, Gene)FDA Link 12/2023 - 09/2015
4	Messenger RNA (mRNA)IBA 05/2022 - 12/2009
4	Imiquimod (Aldara)FDA LinkGeneric 04/2022 - 01/2018
4	CytokinesIBA 01/2019 - 10/2010
4	Formaldehyde (Formol)FDA Link 01/2018 - 09/2004
4	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 09/2015 - 01/2009
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2015 - 08/2009
3	dimethyl trisulfideIBA 10/2023 - 03/2021
3	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2023 - 01/2008
3	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 09/2022 - 02/2015
3	Ion Channels (Ion Channel)IBA 05/2022 - 01/2019
3	Streptozocin (Streptozotocin)FDA Link 02/2021 - 09/2004
3	Amine Oxidase (Copper-Containing)IBA 02/2021 - 01/2017
3	EnzymesIBA 02/2021 - 02/2015
3	GTP-Binding Proteins (G-Protein)IBA 01/2020 - 11/2006
3	CuprizoneIBA 12/2019 - 12/2016
3	Substance PIBA 09/2016 - 06/2007
3	Freund's AdjuvantIBA 01/2016 - 05/2004
3	OxazoloneIBA 01/2016 - 08/2009
3	SolutionsIBA 02/2015 - 07/2011
3	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 05/2014 - 10/2010
2	PolymersIBA 10/2022 - 09/2022
2	SiliconesIBA 10/2022 - 09/2022
2	Sulfides (Thioethers)IBA 09/2022 - 01/2019
2	CationsIBA 01/2022 - 01/2018
2	CreatinineIBA 02/2021 - 03/2016
2	Retinaldehyde (Retinal)IBA 02/2021 - 03/2016
2	Blood Proteins (Serum Proteins)IBA 11/2020 - 01/2012
2	pyrimidineIBA 01/2020 - 12/2019
2	CollagenIBA 10/2018 - 01/2008
2	SodiumIBA 01/2018 - 02/2015
2	Ligand-Gated Ion ChannelsIBA 01/2017 - 06/2013
2	Chemotactic FactorsIBA 01/2017 - 02/2015
2	Type 3 Galanin ReceptorIBA 01/2016 - 01/2016
2	GalaninIBA 01/2016 - 01/2016
2	Dextran SulfateIBA 02/2015 - 05/2014
2	hemokinin-1IBA 02/2015 - 01/2013
2	Calcitonin Gene-Related PeptideIBA 01/2014 - 06/2007
2	2S)- 4- amino- N- (1'- carbamoyl- 2'- phenylethyl)- 2- (4''- methyl- 1''- naphthalenesulfonylamino)butanamide (1'SIBA 01/2008 - 06/2006
1	ChromatinIBA 12/2023
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2022
1	Caffeine (No Doz)FDA LinkGeneric 04/2022
1	9-phenanthrolIBA 01/2022

Therapy/Procedure

8	Ligation 03/2021 - 09/2003
6	Therapeutics 10/2022 - 10/2014
5	Oral Administration 11/2020 - 05/2014
2	Oral Hygiene (Dental Hygiene) 10/2022 - 07/2018
2	Drug Therapy (Chemotherapy) 03/2021 - 10/2019
2	Injections 02/2021 - 01/2018
2	Subcutaneous Injections 01/2008 - 05/2004